Psychological outcomes following maternal serum screening: A cohort study

CMAJ. Canadian Medical Association Journal

Volumn 159, Issue 6, 1998, Pages 651-656

  Goel, Vivek ^a,c,e   Glazier, Richard ^a,b,d   Summers, Anne ^f   Holzapfel, Stephen ^b,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f NORTH YORK GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; CONGENITAL MALFORMATION; DEPRESSION; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; HUMAN EXPERIMENT; MATERNAL BLOOD; NORMAL HUMAN; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PSYCHOLOGICAL ASPECT; SCREENING TEST;

EID: 0032558435     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Carroll JC, Reid AJ, Woodward CA, Permaul-Woods JA, Domb S, Ryan G, et al. Ontario Maternal Serum Screening Program: practices, knowledge and opinions of health care providers. CMAJ 1997;156:775-84.
2. Green JM. Serum screening for Down's syndrome: experiences of obstetricians in England and Wales. BMJ 1994;309:769-72.
3. Chodirker BN, Evans JA. Maternal serum AFP screening programs: the Manitoba experience. In: Current practice of prenatal diagnosis in Canada. vol 13 of Research studies. Ottawa: Royal Commission on New Reproductive Technologies; 1993. p. 535-610. Cat no Z1-1989-3-41-26E.
4. Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med 1978;299:741-4.
5. Croyle RT, editor. Psychosocial effects of screening for disease prevention and detection. New York: Oxford University Press; 1995.
6. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, et al. Prenatal screening for Down syndrome with use of maternal serum markers. N Engl J Med 1992;327:588-93.
7. MacDonald ML, Wagner RM, Slotnick RN. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age. Obstet Gynecol 1991;77:63-8.
8. Wald BJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down syndrome in early pregnancy. BMJ 1988;297:883-92.
9. Norgaard-Pedersen B, Larsen SO, Arends J, Svenstrup B, Tabor A. Maternal serum markers in screening for Down syndrome. Clin Genet 1990;37:35-43.
10. Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE. A prospective evaluation of a second trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Obstet Gynecol 1993;81:72-7.
11. Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL. Maternal serum screening for Down syndrome in women less than 35 years of age using alpha-tetoprotem, hCG, and unconjugated estriol: a prospective 2-year study. Obstet Gynecol 1992;80:353-8.
12. Croyle RT, Lerman C. Psychosocial impact of genetic testing. In: Croyle RT, editor. Psychosocial effects of screening for disease prevention and detection. New York: Oxford University Press; 1995. p. 1-38.
13. Marteau TM. Psychological implications of prenatal diagnosis. In: Dufe JD, Donnai D, editors. Antenatal diagnosis of fetal abnormalities. London: Springer-Verlag; 1991. p. 243-54.
14. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory (Self-Evaluations Questionnaire). Palo Alto (CA): Consulting Psychologists Press; 1970.
15. Radloff LS. The CES-D Scale - a self report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
16. Groel V, Glazier RH, Holzapfel S, Pugh P, Summers A. Evaluating patients' knowledge of maternal serum screening. Prenat Diagn 1996;16:425-30.
17. Turner RJ. Social support: conceptualization, measurement and implications for mental health. Res Community Ment Health 1983;3:67-111.
18. Fearn J, Hibbard BM, Laurence KM, Roberts A, Robinson JO. Screening for neural-tube defects and maternal anxiety. Br J Obstet Gynaecol 1982;89: 218-21.
19. Marteau TM. Towards informed decisions about prenatal testing: a review. Prenat Diagn 1995;15:1215-26.
20. Croyle RT, Sande GN. Denial and confirmatory search: paradoxical consequences of medical diagnoses. J Appl Soc Psychol 1988;18:473-90.
21. Phipps S, Zinn AB. Psychological response to amniocentesis: II. Effects of coping style. Am J Med Genet 1986;25:143-8.